Previous issues
- Page Path
-
- HOME
- BROWSE ARTICLES
- Previous issue
|
- Reviews
- Cost-of-illness studies: concepts, scopes, and methods
- Changik Jo
- Clin Mol Hepatol. 2014;20(4):327-337. Published online December 24, 2014
- Management of viral hepatitis in liver transplant recipients
- Soung Won Jeong, YoungRok Choi, Jin-Wook Kim
- Clin Mol Hepatol. 2014;20(4):338-344. Published online December 24, 2014
- Editorial
- Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
- Hyun Woong Lee
- Clin Mol Hepatol. 2014;20(4):345-346. Published online December 24, 2014
- Original Articles
- Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
- Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
- Clin Mol Hepatol. 2014;20(4):347-354. Published online December 24, 2014
- Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
- Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
- Clin Mol Hepatol. 2014;20(4):355-360. Published online December 24, 2014
-
DOI: https://doi.org/10.3350/cmh.2014.20.4.355 Correction in: Clin Mol Hepatol 2015;21(1):104
- Geographic differences in the epidemiological features of HCV infection in Korea
- Kyung-Ah Kim, Sook-Hyang Jeong, Eun Sun Jang, Young Seok Kim, Youn Jae Lee, Eun Uk Jung, In Hee Kim, Sung Bum Cho, Mee-Kyung Kee, Chun Kang
- Clin Mol Hepatol. 2014;20(4):361-367. Published online December 24, 2014
- Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection
- Yoo-Kyung Cho, Young Nam Kim, Byung-Cheol Song
- Clin Mol Hepatol. 2014;20(4):368-375. Published online December 24, 2014
- Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
- Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim
- Clin Mol Hepatol. 2014;20(4):376-383. Published online December 24, 2014
- Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
- Jung Wha Chung, Gi Hyun Kim, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Sook-Hyang Jeong, Jin-Wook Kim
- Clin Mol Hepatol. 2014;20(4):384-391. Published online December 24, 2014
- Case Reports
- A case of focal nodular hyperplasia with growth progression during pregnancy
- Min Ji Kim, Sang Young Han, Yang Hyun Baek, Sung Wook Lee, Hee Jin Kwon
- Clin Mol Hepatol. 2014;20(4):392-397. Published online December 24, 2014
- Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy
- Soon Young Ko, Byung Kook Kim, Dong Wook Kim, Jeong Han Kim, Won Hyeok Choe, Hee Yeon Seo, So Young Kwon
- Clin Mol Hepatol. 2014;20(4):398-401. Published online December 24, 2014
- Liver Pathology
- Intrahepatic cholangiocarcinoma arising in Caroli's disease
- Min Hye Jang, Yoon Jin Lee, Haeryoung Kim
- Clin Mol Hepatol. 2014;20(4):402-405. Published online December 24, 2014
- Liver Imaging
- Composite liver tumors: A radiologic-pathologic correlation
- Megha Nayyar, David K. Imagawa, Temel Tirkes, Aram N. Demirjian, Roozbeh Houshyar, Kumar Sandrasegaran, Chaitali S. Nangia, Tara Seery, P Bhargava, Joon II Choi, Chandana Lall
- Clin Mol Hepatol. 2014;20(4):406-410. Published online December 24, 2014
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
